Susan D. Wyrick

Insider Reports History

Location
Seattle, WA
Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Susan D. Wyrick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan D. Wyrick:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. SVP, Finance and Accounting and Principal Accounting Officer Common Stock 196,196 $743,582 $3.79 09 Mar 2026 Direct
Sana Biotechnology, Inc. SVP, Finance and Accounting and Principal Accounting Officer Restricted Stock Units 6,500 $24,960 $2.56 07 Mar 2026 Direct
Sana Biotechnology, Inc. SVP, Finance and Accounting and Principal Accounting Officer Stock Option (Right to Buy) 206,250 05 Mar 2026 Direct

Insider Reports Filed by Susan D. Wyrick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SANA Sana Biotechnology, Inc. 06 Mar 2026 6 $0 4 SVP, Finance and Accounting and Principal Accounting Officer 10 Mar 2026, 16:15
SANA Sana Biotechnology, Inc. 05 Mar 2026 2 $0 4 SVP, Finance and Accounting and Principal Accounting Officer 06 Mar 2026, 16:53
SANA Sana Biotechnology, Inc. 02 Mar 2026 3 $0 4 SVP, Finance and Accounting and Principal Accounting Officer 04 Mar 2026, 16:17
SANA Sana Biotechnology, Inc. 02 Jan 2026 3 -$10,278 4 Acting Chief Financial Officer and Principal Accounting Officer 06 Jan 2026, 16:18
SANA Sana Biotechnology, Inc. 13 Dec 2025 3 -$4,557 4 Acting Chief Financial Officer and Principal Accounting Officer 16 Dec 2025, 16:16
SANA Sana Biotechnology, Inc. 06 Mar 2025 5 -$2,140 4 Acting Chief Financial Officer and Principal Accounting Officer 10 Mar 2025, 20:13
SANA Sana Biotechnology, Inc. 02 Mar 2025 3 -$1,254 4 Acting Chief Financial Officer and Principal Accounting Officer 03 Mar 2025, 19:28
SANA Sana Biotechnology, Inc. 02 Jan 2025 3 -$2,584 4 Acting Chief Financial Officer and Principal Accounting Officer 03 Jan 2025, 16:15
SANA Sana Biotechnology, Inc. 13 Dec 2024 8 -$17,344 4 Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney 05 Dec 2025, 17:04
SANA Sana Biotechnology, Inc. 04 Oct 2024 0 $0 3 Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney 15 Oct 2024, 18:43